Neurological side-effects caused by recently approved chemotherapy drugs
How can you get the greatest efficacy from neurotoxic drugs without putting patients at risk of acute or chronic damage to their nervous system? Download full article
chemotherapy
Newsround
Selected reports edited by Janet Fricker Download full article
The no miracle cure’ story
The story of step-by-step progress, with occasional leaps forward and frequent setbacks, is not one the media enjoys telling. But it does need to be told if patients and society are to learn to live [more]
Vested interests are undermining our efforts to beat cancer – The worries of a battle-hardened German oncologist
Cancer treatment is at a critical juncture, says Dieter K Hossfeld, veteran campaigner for the recognition of medical oncology in Germany. Future progress, he believes, depends on reasserting the interests of society at large over [more]
Newsround
Selected reports edited by Janet Fricker Download full article
Decision making for systemic treatment of non-small-cell lung cancer
Non-small-cell lung cancers (NSCLC) covers a heterogeneous group of diseases, accounting for around 80% of all lung cancers, which were previously lumped together because there was no apparent reason to use different therapeutic approaches for [more]
Chemobrain: delving into possible mechanisms
Chemobrain’ is an informal term coined by patients who are or were on chemotherapy, to express the feeling of being not quite switched on or able to think clearly and focus on the [more]
Determining the survival benefit of adjuvant radiotherapy in patients with node-positive head and neck cancer
Postoperative radiotherapy with or without chemotherapy remains part of the standard treatment regimen to improve locoregional control for patients with head and neck cancer who have adverse pathologic factors after surgery. Whether an overall survival [more]
Are metastatic testicular tumours curable with high-dose chemotherapy and stem-cell rescue?
A retrospective study has shown that haematopoietic stem cell rescue in tandem with high-dose chemotherapy should be considered a major treatment option in patients with testicular cancer following first-salvage chemotherapy and/or in cisplatin-refractory disease. Download [more]
N E W S R O U N D
Selected press reports compiled by the ESO Download full article
Does chemotherapy given directly to the liver improve survival in patients with hepatic metastasis?
A study using hepatic arterial infusion to deliver treatment to colorectal cancer patients with liver metastases is unlikely to lead to wholesale changes in clinical practice, but may spur new studies into the role of [more]
Relapsed Hodgkin’s lymphoma: new twist to the standard regimen
Results of a multicentre study show that a sequential high-dose chemotherapy variant of the standard treatment is safe and effective in relapsed Hodgkin’s patients. Download full article
Oncology under the microscope
This latest edition of Cancer: Principles and Practice of Oncology is a one-stop shop for everything you ever wanted to know about oncology. Download full article